Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary E Law

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Molecular Pharmacology|May 29, 2015
Cyclin-Dependent Kinase Inhibitors as Anticancer TherapeuticsMary E Law, Patrick E Corsino, Satya Narayan, et al.
Critical Reviews in Oncology/Hematology|June 13, 2018
The unfolded protein response as a target for anticancer therapeuticsMengxiong Wang, Mary E Law, Ronald K Castellano, et al.
Journal of Cell Science|January 17, 2013
Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpointsStephan C Jahn, Patrick E Corsino, Bradley J Davis, et al.
Biochemistry|May 1, 2013
Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexesStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
Plos One|June 14, 2014
Signaling mechanisms that suppress the cytostatic actions of rapamycinStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
RSC Medicinal Chemistry|June 2, 2025
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposureZaafir M Dulloo, Ion Ghiviriga, Mary E Law, et al.
Iscience|June 27, 2022
Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2ASatya Narayan, Asif Raza, Iqbal Mahmud, et al.
Cancer Letters|August 22, 2012
An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switchStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
Biomolecules|August 28, 2025
Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic TargetsMary E Law, Zaafir M Dulloo, Brian Hardy, et al.
Breast Cancer Research : BCR|August 7, 2016
CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachmentMary E Law, Renan B Ferreira, Bradley J Davis, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Molecular Pharmacology|May 29, 2015
Cyclin-Dependent Kinase Inhibitors as Anticancer TherapeuticsMary E Law, Patrick E Corsino, Satya Narayan, et al.
Critical Reviews in Oncology/Hematology|June 13, 2018
The unfolded protein response as a target for anticancer therapeuticsMengxiong Wang, Mary E Law, Ronald K Castellano, et al.
Journal of Cell Science|January 17, 2013
Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpointsStephan C Jahn, Patrick E Corsino, Bradley J Davis, et al.
Biochemistry|May 1, 2013
Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexesStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
Plos One|June 14, 2014
Signaling mechanisms that suppress the cytostatic actions of rapamycinStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
RSC Medicinal Chemistry|June 2, 2025
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposureZaafir M Dulloo, Ion Ghiviriga, Mary E Law, et al.
Iscience|June 27, 2022
Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2ASatya Narayan, Asif Raza, Iqbal Mahmud, et al.
Cancer Letters|August 22, 2012
An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switchStephan C Jahn, Mary E Law, Patrick E Corsino, et al.
Biomolecules|August 28, 2025
Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic TargetsMary E Law, Zaafir M Dulloo, Brian Hardy, et al.
Breast Cancer Research : BCR|August 7, 2016
CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachmentMary E Law, Renan B Ferreira, Bradley J Davis, et al.
Pageof 2